MDxHealth (MDXH) Gross Margin (2022 - 2026)

MDxHealth (MDXH) posted Gross Margin of 60.67% for Q1 2026, down 4.08% sequentially from 63.25% in Q4 2025, and down 316.0% YoY from 28.09% in Q1 2025.

MDxHealth (MDXH) Gross Margin (2022 - 2026) Analysis & Trends

MDxHealth has reported Gross Margin for 5 years, with the latest figure at 60.67% in Q1 2026.

  • Quarterly Gross Margin fell 316.0% year-over-year to 60.67% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 55.77% (down 622.0% YoY) and the FY2025 annual result came in at 64.55%, up 332.0% from the prior year.
  • Gross Margin slipped to 60.67% in Q1 2026 per MDXH's latest filing, from 63.25% in the prior quarter.
  • Over five years, Gross Margin peaked at 65.32% in Q4 2023 and troughed at 34.51% in Q2 2025.
  • A 5-year average of 59.53% and a median of 60.82% in 2024 frame the typical range for Gross Margin.
  • The sharpest annual moves came in 2023 and 2025: Gross Margin jumped 928 bps in 2023, then sank 2544 bps in 2025.
  • Over 5 years, Gross Margin stood at 56.04% in 2022, then gained by 17 bps to 65.32% in 2023, then fell by 4 bps to 62.72% in 2024, then gained by 1 bps to 63.25% in 2025, then retreated by 4 bps to 60.67% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods registered 60.67%, 63.25%, and 65.04% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn 69.57%
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn 57.64%
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn 64.04%
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn 53.95%
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn 32.85%
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn 99.91%
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn 66.44%
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn 63.29%
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn 33.75%
10 MDxHealth 21.81 Mn -21.34 Mn 16.61 Mn 60.67%

Historic Data

Download Data
DateValue
Mar 31, 2026 60.67%
Dec 31, 2025 63.25%
Sep 30, 2025 65.04%
Jun 30, 2025 34.51%
Mar 31, 2025 63.82%
Dec 31, 2024 62.72%
Sep 30, 2024 61.22%
Jun 30, 2024 59.96%
Mar 31, 2024 60.82%
Dec 31, 2023 65.32%
Sep 30, 2023 64.87%
Jun 30, 2023 59.66%
Mar 31, 2023 59.29%
Dec 31, 2022 56.04%
Sep 30, 2022 55.79%